A TRIAL TO DETERMINE WHETHER TWO DIFFERING STRENGTH TABLETS (3 X 5 MG VERSUS 1 X 15 MG) OF SUBLINGUALLY ORG 5222 (ASENAPINE) ARE SAFE AND EQUAL IN SUBJECTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER (P05937):